- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.06. | Shrinking budgets and rising targets pile pressure on pharma marketers: survey | ||
| 17.06. | Senators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers | ||
| 16.06. | Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short | ||
| 16.06. | Veranova, Enzene plot new biologic manufacturing expansions on East Coast | ||
| 16.06. | Precision medicine's next frontier: unlocking the power of biospecimens | ||
| 16.06. | Supernus acquires struggling Sage for $561M, taking a flier on postpartum depression drug Zurzuvae | ||
| 16.06. | Eli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website | ||
| 16.06. | Sarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients | ||
| 16.06. | AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication | ||
| 16.06. | FDA's 'heavy workload' blamed for delays to KalVista's angioedema drug approval decision | ||
| 16.06. | Biogen leads Cannes Lions Pharma shortlist, with BMS, Novartis cracking Health & Wellness category | ||
| 13.06. | Sens. Sanders, King propose legislation to ban direct-to-consumer ads for prescription drugs | ||
| 13.06. | Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation | ||
| 13.06. | Fierce Pharma Asia-Pfizer CEO talks bispecific deal; Otsuka's kidney disease win; Novartis-MSN Entresto feud | ||
| 13.06. | UroGen's Zusduri wins FDA's blessing as first therapy for certain bladder cancer patients, despite negative adcomm vote | ||
| 12.06. | ADC Therapeutics shutters UK R&D site, culls several preclinical programs and trims workforce by 30% | ||
| 12.06. | UCB touts plan for 'major' US investment to boost biologics capacity | ||
| 12.06. | Bristol Myers CEO stays bullish on Cobenfy despite trial flop, signs of slowing momentum | ||
| 12.06. | Sprout hit with FDA warning letter over CEO's Instagram post about female libido drug Addyi | ||
| 12.06. | AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award | ||
| 12.06. | Havas creates health ad market for reaching underserved patients | ||
| 12.06. | BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal | ||
| 12.06. | RFK Jr. names 8 new members to CDC's vaccine advisory committee after purging entire panel | ||
| 11.06. | David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field | ||
| 11.06. | FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .